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Background: Myocardial scarring, measured by delayed hyperenhancement cardiac magnetic resonance (DHE-CMR) & mitral regurgitation (MR), 
seen in severe ischemic cardiomyopathy (ICM) patients, predicts outcomes. The association between aortic stiffness and outcomes in ICM is not 
well elucidated. We sought to assess the incremental impact of aortic stiffness, myocardial scarring (both measured on CMR) & MR (measured on 
Doppler echocardiography), on survival.
Methods: ICM patients (n = 270, 77% men, 66 ± 11 years, left ventricular ejection fraction or LVEF of 22 % ± 11 & > 70% disease in ≥1 coronary 
artery) were studied. CMR (Siemens 1.5-T scanner) was used to evaluate LV volumes (cine) & scar (inversion recovery DHE-CMR ~ 10-20 minutes 
after injection of 0.2 mmol/kg of Gadolinium). LV scar was measured automatically (> 2 SD above viable myocardium) as % of total LV myocardium. 
Pulse wave velocity (PWV, m/s), a measure of aortic stiffness, was recorded on velocity-encoded CMR as Δ x/Δ t (Δ x = aortic path length between 
mid-ascending & descending aorta, & Δ t = time between arrival of foot of PW between 2 points). MR degree was assessed by vena contracta (cm). A 
composite end-point of cardiac transplantation (CTx) & all-cause mortality were recorded.
Results: Over 3.7 ± 1.7 years, there were 80 events (75 deaths & 5 CTx). Results of Cox Proportional survival analysis are shown in Table.
Conclusions: In severe ICM patients, aortic stiffness, along with degree of MR & LV scar predict outcomes, independent of LVEF and volumes.
Cox Proportional Hazard Analysis of Various Clinical and Imaging Factors and Combined Events
Univariable analysis Multivariable analysis
Variable Hazard ratio (CI) p-value Hazard ratio (CI) p-value
Age 
Female
1.04 (1.01-1.06)
2.06 (1.29-3.28)
0.001 
0.002
1.04 (1.02-1.07)
1.87 (1.17-3.01)
0.001
0.02
Diabetes Mellitus 
Hypertension
1.18 (0.73-1.90)
0.90 (0.56-1.43)
0.5
0.6
Statins
Beta-blockers
0.72 (0.46-1.12)
0.74 (0.47-1.16)
0.14
0.2
Angiotensin converting enzyme-inhibitors
Aldosterone Antagonists
0.75 (0.48-1.18)
0.89 (0.52-1.52)
0.2
0.7
Post-CMR Coronary bypass
Post-CMR mitral surgery
Post-CMR defibrillator/resynchronization
0.63 (0.40-0.99)
1.12 (0.66-1.89)
0.78 (0.46-1.30)
0.04
0.2
0.2
Vena Contracta width 5.08 (2.42-10.67) <0.001 4.22 (1.97-9.03) <0.001
LVEF
LV end-systolic volume index
Indexed left atrial volume
0.99 (0.96-1.01)
1.003(0.99-1.007)
1.004(0.99-1.02)
0.3
0.3
0.4
Mean scar % on CMR
Pulse wave velocity on CMR
1.01(1.001-1.02)
1.02(1.007-1.04)
0.03
0.003
1.02(1.006-1.03)
1.02(1.002-1.034)
0.001
0.01
